The board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares
Moberg Pharma AB (publ) today announces that the board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares, to secure the company’s commitments under incentive programmes and for the purpose of covering certain costs that may arise as a result of incentive programs.The annual general meeting of Moberg Pharma AB (publ) on 14 May 2024 resolved – for the purpose of ensuring that the company can fulfil its commitments under the long-term incentive programme LTI 2024 resolved by the annual general meeting and for the purpose of covering